CollabRx Tapped to Provide Interpretation Resources for CellNetix's Tests | GenomeWeb

NEW YORK (GenomeWeb News) — CollabRx and CellNetix Pathology & Laboratories have signed a multi-year agreement that lets CellNetix make use of CollabRx's technology and content resources in providing sequencing-based testing for oncology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.